CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 1981; 31:322-332
doi: 10.3322/canjclin.31.6.322
© 1981 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammond, C. B.
Right arrow Articles by Tyrey, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammond, C. B.
Right arrow Articles by Tyrey, L.

CA: A Cancer Journal for Clinicians, Vol 31, 322-332, Copyright © 1981 by American Cancer Society

Gestational Trophoblastic Neoplasia

Charles B. Hammond M.D.1, John C. Weed Jr. M.D.2, David E. Barnard M.D.3, and Lee Tyrey Ph.D.4

1 Professor and Chairman of the Department of Obstetrics and Gynecology of Duke University Medical Center in Durham, North Carolina.
2 Associate Professor in the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, of Duke University Medical Center in Durham, North Carolina.
3 Assistant Professor in the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, of Duke University Medical Center in Durham, North Carolina.
4 Associate Professor and Director of the Gynecologic Endocrinology Laboratory, Department of Obstetrics and Gynecology, of Duke University Medical Center in Durham, North Carolina.

As a result of modern diagnostic and therapeutic techniques, nearly 100 percent of patients with GTN can be cured of a disease that only a few years ago had a high death rate. To achieve this, skillful mixing of chemotherapy, surgery, and irradiation, as well as supportive therapy, are necessary. Understanding and utilizing the HCG assay to monitor disease status is vital. With this approach, essentially all of these patients should survive, many to have successful future pregnancies.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by American Cancer Society.